SLC12A5 and central nervous system cancer: By quantitative reverse transcriptase polymerase chain reaction, we detected that the expression of SLC12A5 gradually decreased with the increase of tumour grade and was higher in HA1800 than in other glioma cell lines (Figure 5A,B).